Atenolol and Hypertrophic cardiomyopathy - a phase IV clinical study of FDA data

Summary:

Hypertrophic cardiomyopathy is reported as a side effect among people who take Atenolol (atenolol), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Folic Acid, and have Hypertensive crisis.

The phase IV clinical study analyzes which people have Hypertrophic cardiomyopathy when taking Atenolol. It is created by eHealthMe based on reports of 170,420 people who have side effects when taking Atenolol from the FDA, and is updated regularly.

What is Atenolol?

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 176,618 Atenolol users. Check the latest studies of Atenolol.

What is Hypertrophic cardiomyopathy?

Hypertrophic cardiomyopathy (a condition in which the heart muscle becomes abnormally thick) is found to be associated with 265 drugs and 936 conditions by eHealthMe. Check the latest studies of Hypertrophic cardiomyopathy.

On Jul, 07, 2026

170,420 people reported to have side effects when taking Atenolol.
Among them, 40 people (0.02%) have Hypertrophic cardiomyopathy.

Could Atenolol cause Hypertrophic cardiomyopathy?

Among these 40 people:

How long have people been on Atenolol when they have Hypertrophic cardiomyopathy? *

What is the gender of people who have Hypertrophic cardiomyopathy when taking Atenolol? *

female: 55 %
male: 45 %

What is the age of people who have Hypertrophic cardiomyopathy when taking Atenolol? *

What are other drugs people take besides Atenolol? *

Folic Acid: 10 people, 25.00%
Amlodipine: 9 people, 22.50%
Prednisone: 8 people, 20.00%
Ranitidine: 7 people, 17.50%
Chlorpheniramine Maleate: 6 people, 15.00%
Cimetidine: 6 people, 15.00%
Herceptin: 6 people, 15.00%
Arimidex: 6 people, 15.00%
Perjeta: 6 people, 15.00%
Ondansetron: 6 people, 15.00%

What are other side effects people have besides Hypertrophic cardiomyopathy? *

Fatigue (feeling of tiredness): 11 people, 27.50%
Depression: 9 people, 22.50%
Headache (pain in head): 7 people, 17.50%
Cardiac Failure: 7 people, 17.50%
Thrombocytopenia (decrease of platelets in blood): 6 people, 15.00%
Memory Loss: 6 people, 15.00%
Hyperhidrosis (abnormally increased sweating): 6 people, 15.00%
Joint Pain: 6 people, 15.00%
Stress And Anxiety: 6 people, 15.00%
Chest Pain: 6 people, 15.00%

What are the existing conditions these people have? *

Hypertensive Crisis: 6 people, 15.00%
Breast Cancer Metastatic: 5 people, 12.50%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 5 people, 12.50%
Rickets (softening of bones): 5 people, 12.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 10.00%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 3 people, 7.50%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 7.50%
Osteoporosis (bones weak and more likely to break): 1 person, 2.50%
Prostate Cancer: 1 person, 2.50%
Left Ventricular End-Diastolic Pressure Increased: 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Atenolol and have Hypertrophic cardiomyopathy?

- Check whether Hypertrophic cardiomyopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atenolol:

Atenolol (176,618 reports)

Browse all side effects of Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertrophic cardiomyopathy:

Hypertrophic cardiomyopathy (265 drugs)

Browse all the conditions that are associated with Hypertrophic cardiomyopathy:

Hypertrophic cardiomyopathy (936 conditions)

Related publications that referenced our studies

Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on atenolol (the active ingredients of Atenolol) and Atenolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.